Back to Search
Start Over
High
- Source :
- Clinical cancer research : an official journal of the American Association for Cancer Research. 28(1)
- Publication Year :
- 2021
-
Abstract
- Here, we used preclinical models and patient samples to identify predictive biomarkers to these drugs. We evaluated the antitumor activity of an FGFRi and an MTKI in a collection of 17 breast cancer patient-derived xenografts (PDXs) harboring amplification inHighTailored therapy with FGFRis in molecularly selected MBC based on high
Details
- ISSN :
- 15573265
- Volume :
- 28
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Accession number :
- edsair.pmid..........71fd83e5fb4ac295ad4a43b29d7c24f4